Lucite deal tombstone commemorating an agreement for global rights to gout treatment drug ARO-XDH. The agreement was reached between Dublin, Ireland-based Horizon Therapeutics and Arrowhead Pharmaceuticals, headquartered in Pasadena, California.
(21ALJ356)Lucite deal toy marking the acquisition of Prisym ID, a Massachusetts-based company specializing in labeling for clinical trials, medical devices, and pharmaceuticals. The acquirer, Loftware, is the largest global software firm focused on enterprise labeling and artwork management.
(22AKL039)Custom crystal tombstone celebrating a second close of Series A financing for Fusion Pharmaceuticals. The Hamilton, Ontario-based firm is focused on radiotherapeutics for treating cancer.
(8ALJ479)Lucite deal toy celebrating a license option agreement between Ironwood Pharmaceuticals and COUR, a biotech firm. The agreement centers on COUR’s therapy for PBC, a rare autoimmune disease affecting the liver.
(22ALJ081)Custom tombstone marking the divestment of U.S. right to Doryx by Actavis. Actavis is headquartered in Dublin, Ireland.
(5SNR551)Lucite commemorative celebrating the first anniversary of FDA approval of Imbruvica. Imbruvica is an inhibitor used in the treatment of three different kinds of blood cancers.
